chr3-124740091-T-A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_000373.4(UMPS):​c.1050T>A​(p.Val350Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0166 in 1,614,088 control chromosomes in the GnomAD database, including 489 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 37 hom., cov: 32)
Exomes 𝑓: 0.017 ( 452 hom. )

Consequence

UMPS
NM_000373.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: -0.736

Publications

13 publications found
Variant links:
Genes affected
UMPS (HGNC:12563): (uridine monophosphate synthetase) This gene encodes a uridine 5'-monophosphate synthase. The encoded protein is a bifunctional enzyme that catalyzes the final two steps of the de novo pyrimidine biosynthetic pathway. The first reaction is carried out by the N-terminal enzyme orotate phosphoribosyltransferase which converts orotic acid to orotidine-5'-monophosphate. The terminal reaction is carried out by the C-terminal enzyme OMP decarboxylase which converts orotidine-5'-monophosphate to uridine monophosphate. Defects in this gene are the cause of hereditary orotic aciduria. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
UMPS Gene-Disease associations (from GenCC):
  • orotic aciduria
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 3-124740091-T-A is Benign according to our data. Variant chr3-124740091-T-A is described in ClinVar as Benign. ClinVar VariationId is 100129.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.736 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0572 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UMPSNM_000373.4 linkc.1050T>A p.Val350Val synonymous_variant Exon 4 of 6 ENST00000232607.7 NP_000364.1 P11172-1A8K5J1
UMPSNR_033434.2 linkn.916T>A non_coding_transcript_exon_variant Exon 3 of 5
UMPSNR_033437.2 linkn.1169T>A non_coding_transcript_exon_variant Exon 5 of 7
UMPSXR_001740253.3 linkn.1274T>A non_coding_transcript_exon_variant Exon 4 of 4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UMPSENST00000232607.7 linkc.1050T>A p.Val350Val synonymous_variant Exon 4 of 6 1 NM_000373.4 ENSP00000232607.2 P11172-1

Frequencies

GnomAD3 genomes
AF:
0.0140
AC:
2124
AN:
152094
Hom.:
36
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00355
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0291
Gnomad ASJ
AF:
0.0112
Gnomad EAS
AF:
0.0627
Gnomad SAS
AF:
0.0532
Gnomad FIN
AF:
0.00623
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0121
Gnomad OTH
AF:
0.0105
GnomAD2 exomes
AF:
0.0245
AC:
6149
AN:
251454
AF XY:
0.0253
show subpopulations
Gnomad AFR exome
AF:
0.00258
Gnomad AMR exome
AF:
0.0415
Gnomad ASJ exome
AF:
0.00863
Gnomad EAS exome
AF:
0.0691
Gnomad FIN exome
AF:
0.00702
Gnomad NFE exome
AF:
0.0124
Gnomad OTH exome
AF:
0.0199
GnomAD4 exome
AF:
0.0169
AC:
24727
AN:
1461876
Hom.:
452
Cov.:
32
AF XY:
0.0178
AC XY:
12954
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.00221
AC:
74
AN:
33480
American (AMR)
AF:
0.0420
AC:
1880
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00803
AC:
210
AN:
26136
East Asian (EAS)
AF:
0.0780
AC:
3098
AN:
39700
South Asian (SAS)
AF:
0.0517
AC:
4459
AN:
86256
European-Finnish (FIN)
AF:
0.00713
AC:
381
AN:
53420
Middle Eastern (MID)
AF:
0.00538
AC:
31
AN:
5762
European-Non Finnish (NFE)
AF:
0.0122
AC:
13555
AN:
1112002
Other (OTH)
AF:
0.0172
AC:
1039
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
1403
2806
4209
5612
7015
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
596
1192
1788
2384
2980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0140
AC:
2135
AN:
152212
Hom.:
37
Cov.:
32
AF XY:
0.0150
AC XY:
1119
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.00356
AC:
148
AN:
41536
American (AMR)
AF:
0.0296
AC:
453
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0112
AC:
39
AN:
3472
East Asian (EAS)
AF:
0.0629
AC:
326
AN:
5186
South Asian (SAS)
AF:
0.0530
AC:
255
AN:
4810
European-Finnish (FIN)
AF:
0.00623
AC:
66
AN:
10600
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0121
AC:
822
AN:
68006
Other (OTH)
AF:
0.0118
AC:
25
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
104
208
311
415
519
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0115
Hom.:
6
Bravo
AF:
0.0142
Asia WGS
AF:
0.0490
AC:
169
AN:
3478
EpiCase
AF:
0.0116
EpiControl
AF:
0.0108

ClinVar

Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Diasio Lab, Mayo Clinic
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Oroticaciduria Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Hereditary orotic aciduria, type 1 Benign:1
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
1.7
DANN
Benign
0.73
PhyloP100
-0.74
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2291078; hg19: chr3-124458938; COSMIC: COSV51737943; COSMIC: COSV51737943; API